trending Market Intelligence /marketintelligence/en/news-insights/trending/iaa8cRmDU5GpeLUAADLHIw2 content esgSubNav
In This List

Azaya Therapeutics to sell Cytori shares in secondary offering

Case Study

Identifying PPE Suppliers During the Pandemic

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective


Azaya Therapeutics to sell Cytori shares in secondary offering

Azaya Therapeutics Inc. plans to sell all the Cytori Therapeutics Inc. shares it owns.

The company will sell 1,173,241 Cytori shares at a proposed maximum aggregate offering price of $1.62 apiece for $1.9 million in proceeds. Cytori will receive no proceeds from the sale.

Cytori previously issued the shares when it acquired certain assets from Azaya Therapeutics.